Review of clinical radioimmunotherapy

Expert Review of Anticancer Therapy
Brad PohlmanRoger M Macklis

Abstract

Radioimmunotherapy involves a form of biologically targeted radiopharmaceutical treatment in which a radioactive isotope (typically a short-range, high-energy beta-emitter) is chemically bound to a target-specific monoclonal antibody or fragment. Thus, these radioimmunoconjugates combine the exquisite targeting specificity of the humoral immune system with the known cancer-killing power of high-energy radiotherapy. To date, two radioimmunotherapy agents have been fully approved for commercial use: 90Yttrium ibritumomab tiuxetan and (131)Iodine tositumomab. Both compounds target the CD20 surface molecule found on normal and malignant B cells, and both are medically indicated for the treatment of indolent B-cell lymphoma and related conditions. Clinical results are excellent (20-40% complete response rates and 60-80% overall response rates) and toxicity is typically quite mild. Current research is now attempting to both explore the biology of these compounds and to expand the spectrum of CD20+ diseases that could be treated using either or both of these active agents. Concurrently, work is in progress to achieve the same excellent clinical results using antibodies specific for other, more common epithelial tumors. This work is at...Continue Reading

References

Aug 1, 1990·JAMA : the Journal of the American Medical Association·R M Macklis
May 1, 1988·International Journal of Radiation Oncology, Biology, Physics·P K LeichnerS E Order
Oct 20, 1983·The New England Journal of Medicine·H R MaxonE L Saenger
Aug 12, 1993·The New England Journal of Medicine·M S KaminskiG M Butchko
Oct 21, 1993·The New England Journal of Medicine·O W PressB Porter
Jul 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S KaminskiR L Wahl
Oct 23, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D G MaloneyR Levy
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinB K Dallaire
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T E WitzigA J Grillo-López
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M VoseM S Kaminski
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Feb 7, 2001·Cancer Immunology, Immunotherapy : CII·D ShanO W Press
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·M C JoinerI Turesson
Jul 4, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T SagaJ Konishi
Oct 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S KaminskiJ M Vose
Oct 18, 2001·Cancer Biotherapy & Radiopharmaceuticals·R F MeredithA F LoBuglio
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Feb 15, 2002·British Journal of Haematology·L E van der KolkM H van Oers
Jun 25, 2002·Journal of Clinical Immunology·Nicole SelenkoWalter Knapp
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E WitzigChristine A White
Oct 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D HainsworthF Anthony Greco
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E WitzigPratik S Multani
Aug 16, 2003·The Journal of Biological Chemistry·Haidong LiJulie P Deans
Jan 8, 2004·Seminars in Oncology·M Carmen Hernandez, Susan J Knox
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Tony S Quang, Luther W Brady
Apr 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J DaviesJ A Radford
Jul 28, 2004·International Journal of Radiation Oncology, Biology, Physics·Roger M Macklis
Jul 28, 2004·International Journal of Radiation Oncology, Biology, Physics·M Carmen Hernandez, Susan J Knox
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Myron S CzuczmanAntonio J Grillo-López

❮ Previous
Next ❯

Citations

Dec 15, 2010·Nature Reviews. Clinical Oncology·Naoko TakebeS Percy Ivy
Sep 27, 2006·Cancer Biotherapy & Radiopharmaceuticals·Huguette Albrecht, Sally J DeNardo
Jul 14, 2007·Cancer Biotherapy & Radiopharmaceuticals·Ali SheikholvaezinTorgny Stigbrand
Aug 6, 2013·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Ton That Ai LongIlya Trakht
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Diane E MilenicMartin W Brechbiel
Aug 9, 2008·International Journal of Nanomedicine·Stavroula Sofou
Mar 1, 2011·Therapeutic Delivery·Robert A BeckmanAndrew M Scott
Jun 13, 2014·Science Translational Medicine·Jamey P WeichertJohn S Kuo
Oct 6, 2006·Expert Review of Anticancer Therapy·Alessandra FerrajoliMichael J Keating
Jan 8, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Neeraj SinghGanesh Shidham
Nov 15, 2006·Clinical Lymphoma & Myeloma·Amanda Wedgwood, Anas Younes
Dec 7, 2007·Free Radical Biology & Medicine·Damodar GuptaRoger M Macklis
Oct 9, 2007·Nuclear Medicine and Biology·C Andrew Boswell, Martin W Brechbiel
Nov 23, 2006·Journal of Peptide Science : an Official Publication of the European Peptide Society·Haiteng Deng
Jun 27, 2007·Seminars in Radiation Oncology·Roger M Macklis
Sep 19, 2012·Computational and Mathematical Methods in Medicine·Chen-Yu HuangBarry J Allen
Sep 13, 2006·International Journal of Radiation Oncology, Biology, Physics·Roger M Macklis, Brad Pohlman
Jun 6, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·H GhaffariH Abdollahi
Feb 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maneesh JainSurinder K Batra
Jun 20, 2021·Cancer Research·Li-Chung TsaoZachary C Hartman

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Related Papers

European Journal of Nuclear Medicine and Molecular Imaging
Ilse Novak-Hofer, P August Schubiger
© 2021 Meta ULC. All rights reserved